Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation

Go back to Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
(NASDAQ: ESLA) Delayed: 0.93 -0.02 (2.11%)
Previous Close $0.95    52 Week High
Open $0.94    52 Week Low
Day High $1.03    P/E N/A 
Day Low $0.90    EPS
Volume 49,437